LAPTM4B mRNA and/or protein was also overexpressed in a wide variety of cancers such as hepatocellular carcinoma, gallbladder carcinoma, uterine cancer, ovarian cancer, extrahepatic cholangiocarcinoma [4], [19], [20], [21]. Here, LAPTM4B is linked to hepatocellular carcinoma.